Brief: Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., As Chief Medical Officer
01/10/2026 12:05
BRIEF-Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., As Chief Medical Officer Oct 1 (Reuters) - Iovance Biotherapeutics Inc IOVA.O:
IOVANCE BIOTHERAPEUTICS APPOINTS NOAH BERKOWITZ, M.D., PH.D., AS CHIEF MEDICAL OFFICER
Source text: ID:nGNX74bzhC
Further company coverage: IOVA.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Iovance Biotherapeutics
See all newsBrief: Iovance Biotherapeutics Reports Inducement Grants
US RESEARCH ROUNDUP-BlackRock, Evercore, Goldman Sachs
Brief: Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., As Chief Medical Officer
Iovance hits two-year high after raising annual revenue forecast
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies